Citizens JMP lowered the firm’s price target on Tela Bio (TELA) to $7 from $12 and keeps an Outperform rating on the shares. Sales in the ...
Shares of Tela Bio (NASDAQ:TELA) plunged in the morning hours on Friday after the maker of OviTex surgical mesh fell short of ...
Piper Sandler analyst Matt O’Brien downgraded Tela Bio (TELA) to Neutral from Overweight with a price target of $2, down from $5, after the ...
MALVERN, Pa., Feb. 27, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results